Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -285.00% is 52% below its 5-year average of -187.55%, around the middle of its 5-year range (-615.45%–0.00%).
12.91% below its 12-month average of -252.42%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -206.19%.
NET PROFIT MARGIN
-285.00%
NET PROFIT MARGIN AVG TTM
-252.42%
NET PROFIT MARGIN AVG 3Y
-252.51%
NET PROFIT MARGIN AVG 5Y
-187.55%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-12.91%
CURRENT VS 3Y AVG
-12.87%
CURRENT VS 5Y AVG
-51.96%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-109515.38%
vs the sector median at left
20/20 Biolabs Inc.
Market Cap
$4.33M
Net Profit Margin
-285.00%
TTM Avg
-252.42%
3Y Avg
-252.51%
5Y Avg
-187.55%
Market Cap
$4.27M
Net Profit Margin
-3934.91%
TTM Avg
-1854.81%
3Y Avg
-2358.55%
5Y Avg
-1587.79%
Market Cap
$4.55M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$4.11M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$4.67M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$4.66M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$3.98M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
64.44%
5Y Avg
-64.28%
Market Cap
$4.71M
Net Profit Margin
-118.27%
TTM Avg
-13237.88%
3Y Avg
-7961.50%
5Y Avg
-5307.67%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| 20/20 Biolabs Inc. (AIDX) | $4.33M | -285.00% | -252.42% | -252.51% | -187.55% |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.27M | -3934.91% | -1854.81% | -2358.55% | -1587.79% |
| GRI Bio, Inc. (GRI)vs › | $4.22M | N/A | 0.00% | 0.00% | -421.83% |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.55M | 0.00% | 0.00% | 0.00% | 0.00% |
| Processa Pharmaceuticals, Inc. (PCSA)vs › | $4.11M | 0.00% | 0.00% | 0.00% | 0.00% |
| PharmaCyte Biotech, Inc. (PMCB)vs › | $4.67M | 0.00% | 0.00% | 0.00% | 0.00% |
| CalciMedica, Inc. (CALC)vs › | $4.66M | 0.00% | 0.00% | 0.00% | 0.00% |
| Aptevo Therapeutics Inc. (APVO)vs › | $3.98M | 0.00% | 0.00% | 64.44% | -64.28% |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.71M | -118.27% | -13237.88% | -7961.50% | -5307.67% |
| 60 Degrees Pharmaceuticals, Inc. (SXTP)vs › | $3.83M | -730.23% | -1020.41% | -1573.84% | -1133.48% |
Operating Margin
-162.9%
Net Profit Margin
-285.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -206.19% |
| 2026-03-31 | -615.45% |
| 2025-12-31 | -242.96% |
| 2025-09-30 | -197.51% |
| 2025-06-30 | 0.00% |
| 2024-12-31 | -232.99% |
| 2024-09-30 | -518.97% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | -511.03% |
| 2023-03-31 | -475.66% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
